Promises
1 promise
Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →Global Health Limited — Q3 FY26
Global Health reported Q3 FY26 total income of ₹1,142.8 crore, up 19% YoY, driven by sustained momentum across hospitals.
neutral
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Global Health reported Q3 FY26 total income of ₹1,142.8 crore, up 19% YoY, driven by sustained momentum across hospitals. Consolidated EBITDA (including NOIA) stood at ₹249.4 crore with margins of 21.8%, impacted by early-stage losses at the new NOIA hospital (₹320 million EBITDA loss on ₹343 million revenue). PAT was ₹950 million, including a one-time ₹366 million exceptional charge from new labor codes. Mature hospitals grew 9% YoY with 23.9% margins, while developing hospitals (ex-NOIA) grew 22% with 31.7% margins. Management guided for ARP growth of 5-7% annually and expects NOIA losses to moderate as ramp-up continues. Key risk: potential margin pressure from ongoing talent competition and cost inflation.
ग्लोबल हेल्थ ने तीसरी तिमाही में ₹1,142.8 करोड़ की कमाई की, जो पिछले साल से 19% ज्यादा है। इसका मुख्य कारण अस्पतालों का अच्छा प्रदर्शन है। कंपनी का मुनाफा (EBITDA) ₹249.4 करोड़ रहा, जो कमाई का 21.8% है। नए NOIA अस्पताल में शुरुआती घाटे के कारण यह मार्जिन कम हुआ है—वहां ₹34.3 करोड़ की कमाई पर ₹32 करोड़ का नुकसान हुआ। कुल मुनाफा (PAT) ₹95 करोड़ रहा, जिसमें नए श्रम कानूनों के कारण ₹36.6 करोड़ का एकमुश्त खर्च शामिल है। पुराने अस्पतालों में 9% और नए अस्पतालों (NOIA को छोड़कर) में 22% की बढ़ोतरी हुई। कंपनी को उम्मीद है कि NOIA का घाटा धीरे-धीरे कम होगा और मरीजों से औसत कमाई सालाना 5-7% बढ़ेगी। मुख्य जोखिम: प्रतिभा प्रतिस्पर्धा और बढ़ती लागत से मार्जिन पर दबाव।
Promises0 met · 1 missedRisks3 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
3 risks
Risk Intelligence
Talent competition and cost inflation
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Inpatient Volume Growth
14%
+14% YoY
Inpatient volumes grew 14% year-on-year across the network.
Outpatient Volume Growth
20%
+20% YoY
Outpatient volumes increased 20% year-on-year.
Average Length of Stay (ALOS)
3.02 days
-7% YoY
ALOS reduced to 3.02 days, a 7% improvement year-on-year.
ARPOP
₹67,361
+10% YoY
ARPOP increased 10% to ₹67,361, supported by ALOS improvement and case mix.
What Changed vs Last Quarter
NEW
ARP growth of 5-7% annually
Management expects ARP to grow 5-7% per year, with a more conservative internal projection of 3-5%.
NEW
FY27 capex below ₹500 crore
Next year's capex is expected to be below ₹500 crore, significantly lower than the ~₹1,000 crore in FY26, as major NOIA construction is complete.
NEW
NOIA losses expected to moderate
Management indicated that Q3 losses at NOIA are likely near peak and should reduce as the hospital ramps up.
DROPPED
Noida hospital to ramp up with 550 beds fully operational
The Noida facility started with 226 beds in September; plans to add beds continuously, targeting full 550-bed capacity over coming quarters.
DROPPED
Mumbai hospital expanded to 750 beds with ₹1,530 crore project cost
Board approved increased bed capacity from 500 to 750 at Oshiwara, with total project cost of ₹15,300 million including land and equipment.
DROPPED
Guwahati hospital construction to begin after Bhoomi Pujan
Land acquisition completed for 400+ bed super-specialty hospital; construction to start post-October 2025 ceremony.
NEW RISK
Talent competition and cost inflation
Management acknowledged a 'war for talent' that could increase employee costs and pressure margins.
NEW RISK
Insurance contract renegotiation pressure
Analyst raised concerns about insurer-hospital tiffs; management downplayed but noted ongoing commercial negotiations that could impact pricing.
NEW RISK
NOIA ramp-up uncertainty
Management declined to provide a timeline for NOIA EBITDA breakeven, citing dependence on occupancy and case mix.
RISK GONE
CGHS payment delays and working capital strain
Government business (CGHS/ECHS) takes 7-8 months for realization; new portal transition may cause further delays and require working capital investment.
RISK GONE
Mature hospital EBITDA growth lagging revenue
Mature hospitals' EBITDA grew only 2.2% YoY (adjusted) due to manpower cost increases and higher base from vector-borne diseases last year.
RISK GONE
Clinical talent retention and competition
Attracting and retaining high-quality ethical clinical talent remains a challenge across the industry, especially in full-time model.
Fast read
Guidance and risk preview
Management expects ARP to grow 5-7% per year, with a more conservative internal projection of 3-5%.
Management acknowledged a 'war for talent' that could increase employee costs and pressure margins.
View Risks →